Page URL:

£13 million investment for UK pluripotent stem cell database

12 November 2012
Appeared in BioNews 681

The Wellcome Trust and Medical Research Council have announced a £12.75 million investment to create a database of iPS cells (induced pluripotent stem cells).

The Human Induced Pluripotent Stem Cell Initiative (HIPSCI) aims to use the iPS cell database to study the effects of genetic variation on human health and disease and facilitate the translation of genetic research into clinical applications. The initiative will also provide the foundation for the creation of an iPS cell bank.

The HIPSCI project will be led by King's College London and the Wellcome Trust Sanger Institute, and will involve collaborations with a number of research institutions, including the University of Cambridge, the University of Dundee and University College London (UCL).

The initiative will generate iPS cells from 1,000 healthy volunteers and people with genetic diseases. Researchers will investigate the effect of genetic variation on the behaviour of the cells - how they transform into specialised cell types and behave in response to external stimuli. Collaboration with NHS investigators will link clinical information to these genetic studies.

Professor Fiona Watt, Director of the Centre for Stem Cells and Regenerative Medicine at King's College London, said: 'The Human Induced Pluripotent Stem Cell Initiative brings together world-leading expertise in clinical genetics, stem cell biology and genomic technologies. We believe that this research will drive forward the translation of basic research into improved diagnosis and treatment of disease'.

Sir Mark Walport, director of the Wellcome Trust, said: 'The field of [iPS] cell research was made possible thanks to the seminal discoveries of Sir John Gurdon and Shinya Yamanaka, who were last month awarded the Nobel Prize for Medicine or Physiology for their work.

'This is a field in which the UK remains at the cutting edge. Our investment in this new initiative should further strengthen the UK's position and lead to patient benefit'.

Professor Sir John Savill, Chief Executive of the MRC, said: 'By investing in a UK-wide initiative in iPS cell technology, we hope to propel UK researchers to the forefront of this rapidly evolving field and provide an invaluable stock of high-quality cell lines for use by academia and industry alike'.

Wellcome Trust and MRC invest £13m to create a new national stem cell resource
Wellcome Trust (press release) |  6 November 2012
Wellcome Trust, MRC Launch $20M Stem Cell Resource
Genomeweb |  6 November 2012
15 May 2017 - by Shaoni Bhattacharya 
One of the world's largest sets of human stem cell lines from healthy people was unveiled last week...
16 September 2013 - by Antony Starza-Allen 
A Singaporean-based company has become the first company to offer iPS cell banking to the public...
25 March 2013 - by Dr Shanya Sivakumaran 
The California Institute for Regenerative Medicine in San Francisco, USA, has awarded two multimillion-dollar grants to Cellular Dynamics International in Wisconsin and Coriell Institute for Medical Research in New Jersey to generate and bank iPS cell lines....
17 December 2012 - by Alison Cranage 
Scientists have converted kidney cells from human urine into brain cells, bypassing the need for embryonic stem cells...
3 September 2012 - by Dr Lux Fatimathas 
The Medical Research Council has awarded £60 million to the University of Edinburgh to advance research into human genetic diseases...
28 August 2012 - by James Brooks 
I'll brook no cynicism, the Olympics was a dazzling display of what makes Britain great. Which is to say: marketing, PR and weapons-grade hype...
13 August 2012 - by Matthew Young 
The anti-doping laboratories built for the London 2012 Olympic and Paralympic Games will be developed into the world's first Phenome Research Centre; the term 'phenome' referring to the overall expression of a person's characteristics and traits as determined by the interaction of genetics and environment...
25 June 2012 - by Antony Starza-Allen 
Six major UK research funding bodies have called for the continued funding of human embryonic stem cell (hESC) research in the EU's programme for research and development...
12 December 2011 - by Victoria Kay 
The world's first 'clinical grade' human embryonic stem cells have been donated to the UK Stem Cell Bank (UKSCB). The high quality cell lines are expected to become the gold standard for developing new cell-based therapies for serious medical conditions, including spinal cord injuries...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.